tbuckley/cabot-search huggingface dataset:
A scoping review on pediatric sepsis prediction technologies in healthcare
Authors: Ryan Tennant, Jennifer Graham, Juliet Kern, Kate Mercer, J. Mark Ansermino, Catherine M. Burns
Journal: npj Digital Medicine (2024)

This scoping review evaluates recent advancements in data-driven technologies for predicting non-neonatal pediatric sepsis, including artificial intelligence, machine learning, and other methodologies. Of the 27 included studies, 23 (85%) were single-center investigations, and 16 (59%) used logistic regression. Notably, 20 (74%) studies used datasets with a low prevalence of sepsis-related outcomes, with area under the receiver operating characteristic scores ranging from 0.56 to 0.99. Prediction time points varied widely, and development characteristics, performance metrics, implementation outcomes, and considerations for human factors—especially workflow integration and clinical judgment—were inconsistently reported. The variations in endpoint definitions highlight the potential significance of the 2024 consensus criteria in future development. Future research should strengthen the involvement of clinical users to enhance the understanding and integration of human factors in designing and evaluating these technologies, ultimately aiming for safe and effective integration in pediatric healthcare.
Estimated Reduction in Health Care Spending Associated With Weight Loss in Adults
Authors: Kenneth E. Thorpe, Peter J. Joski
Journal: JAMA Network Open (2024)

Importance Recent data from federal surveys show that more than 70% of adults have either overweight or obesity. Overweight and obesity are associated with several expensive chronic conditions, such as type 2 diabetes, heart disease, hypertension, and hyperlipidemia. The prevalence of chronic disease is a key driver of rising health care spending among employers and the Medicare program. Objective To estimate health care spending among adults with overweight or obesity and have employer-sponsored insurance or Medicare and examine the association of higher and lower body mass index (BMI). Design, Setting, and Participants This cross-sectional study included privately insured adults and adult Medicare beneficiaries with a BMI of 25 and higher. Data from the Medical Expenditure Panel Survey–Household Component were used to tabulate total annual health care spending. Data were analyzed from April 1 to June 20, 2024. Main Outcomes and Measures The primary intended measures were total annual health care spending, controlling for patient demographics, income, education, and BMI. The baseline health care spending as a percentage reduction in BMI. An instrumental variable regression model with estimated total spending at various levels of BMI was used. Results This study included 3774 adults who were insured with Medicare (mean [SD] age, 63.1 [11.1] years; mean [SD] percentage female, 50.4% [49.7%]; mean [SD] percentage non-Hispanic Black adults, 17.4% [37.7%]; mean [SD] percentage non-Hispanic White adults, 61.3% [48.4%]). The study also included 13 435 adults who had employer-sponsored insurance (mean [SD] age, 46.3 [6.9] years; mean [SD] percentage female, 47.6% [48.9%]; mean [SD] percentage non-Hispanic Black adults, 11.1% [30.7%]; mean [SD] percentage non-Hispanic White adults, 73.1% [43.4%]). Overall, adults with employer-sponsored insurance with a weight loss of 5% were estimated to spend a mean of $670 (95% CI, $654-$686) less on health care (8% less), and those with a weight loss of 25% spent an estimated mean of $2849 (95% CI, $2783-$2916) less on health care (34% less). Among adults with Medicare who had 1 or more comorbid conditions, a 5% weight loss was estimated to reduce spending by $1262 (95% CI, $1217-$1306) (7% less) and a 25% weight loss was estimated to reduce health care spending by a mean of $5442 (95% CI, $5254-$5629) (31% less). Conclusions and Relevance In this cross-sectional study, projected annual savings from weight loss among US adults with obesity were substantial for both Medicare and employer-based insurance.
Neoadjuvant Exercise Therapy in Patients With Prostate Cancer—Reply
Authors: Lee W. Jones, Behfar Ehdaie, Paul C. Boutros
Journal: JAMA Oncology (2024)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast JAMA+ AI Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition
Authors: Alexander S. Rabin, Julien B. Weinstein, Taylor N. Whittington, Cainnear K. Hogan, Deborah Khachikian, Sarah M. Seelye, Hallie C. Prescott
Journal: JAMA Network Open (2024)

This quality improvement study analyzes prescribing patterns among US Department of Veterans Affairs facilities after a July 2021 metered-dose inhaler (budesonide-formoterol) to dry-powder inhaler (fluticasone-salmeterol) national formulary transition.
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database
Authors: S. Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, Xiwu Lin, Sacheeta Bathija, Niodita Gupta-Werner, Annette Lam, Robin Carson, Robyn Dennis, Shuchita Kaila, Kathryn Matt, Joana Duran, Sagar Lonial
Journal: Blood Cancer Journal (2024)

Abstract This study aimed to provide real-world evidence on progression risk in patients with high-risk smoldering multiple myeloma (SMM). This retrospective, observational study leveraged data from the Flatiron Health database. Eligible patients had SMM and relevant measures to apply Mayo 2018, International Myeloma Working Group (IMWG) 2020, and AQUILA trial risk criteria. Time to progression to active MM (TTP), progression or death (PFS), and death or progression on first-line MM therapy (PFS2) were evaluated using Kaplan–Meier methods and multivariate Cox regression models adjusted for age, Charlson Comorbidity Index, and time from SMM diagnosis to risk classification date. Across the three risk models (Mayo 2018, IMWG 2020, and AQUILA trial), high-risk patients with SMM had 3.0–4.0 times the risk of TTP, 2.1–3.5 times the risk of PFS, and 1.7–3.2 times the risk of PFS2 versus non-high-risk patients ( p &lt; 0.001 for all comparisons). Similar results were observed when patients with early treatment, early progression, and/or bone disease were excluded. This study demonstrates that high-risk patients with SMM have worse prognoses than non-high-risk patients, regardless of the criteria used, and highlights a need for early intervention testing.
Effect Analysis of 33 Patients with Corticosteroids Resistant Grade III/IV Acute Liver Graft-Versus-Host Disease Treated with Sequential Low-Dose Cyclophosphamide and Anti-Thymocyte Globulin Following Plasma Exchange
Authors: Juan Wang, Yingling Zu, Ruirui Gui, Zhen Li, Wenli Zhang, Xiangke Xin, Yanli Zhang, Wenyi Lu, Yuewen Fu, Keshu Zhou, Jian Zhou
Journal: Blood (2024)
Impact of Donor Age and Gender on Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Matthew McGuirk, Moazzam Shahzad, Sohaib Irfan, Muhammad Kashif Amin, Sibgha Gull Chaudhary, Iqra Anwar, Shaun DeJarnette, Leyla O. Shune, Al-Ola Abdallah, Anurag K. Singh, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Comparison of Two Myeloablative Total-Body Irradiation (MAC-TBI) Regimens: 1200 Cgy Vs 800 Cgy of TBI for Allogeneic Stem Cell Transplantation in Adults with Hematological Malignancies
Authors: Gabriela Sanchez-Petitto, Ying Huang, Evandro Bezerra, Jonathan E. Brammer, Hannah Choe, Nathan Denlinger, Polina Shindiapina, Sam Penza, Sarah A Wall, Gregory K Behbehani, James S. Blachly, Bradley Wayne Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole R. Grieselhuber, Kristin L Koenig, Karilyn T. Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Ayman Saad, Sumithira Vasu, Marcos de Lima
Journal: Blood (2024)
Bezlotoxumab As Treatment for Recurrent/Chronic <i>Clostridioides Difficile</i> Infection in Stem Cell Transplant Recipients
Authors: Aaron E Fan, Natalie Dailey Garnes, Dristhi Ragoonanan, Priti Tewari, Demetrios Petropoulos, Sajad Khazal, Irtiza Sheikh
Journal: Blood (2024)
Reliable Assessment of Iron Deficiency in Patients with Myeloproliferative Neoplasms through Fluorescence Spectroscopy-Based Measurement of Zinc Protoporphyrin (ZPP)
Authors: Kirsi Manz, Myriam Kobrosly, Carl C Crodel, Haifa Kathrin Al-Ali, Susanne Isfort, Gernot Beutel, Victoria Panagiota, Felicitas R. Thol, Stefanie Jilg, Thomas Stauch, Wolfgang Hoffmann, Henry Völzke, William H Krüger, Andreas Hochhaus, Francesca Palandri, Tina M Schnoeder, Christian Homann, Florian H. Heidel
Journal: Blood (2024)
<i>HoxBlinc</i> LncRNA Reprograms CTCF Independent TADs to Drive Leukemic Transcription and HSC Dysregulation in NUP98 Fusion Transformed Leukemia
Authors: Karina Hamamoto, Ganqian Zhu, Julia Lesperance, Huacheng Luo, Ying D Li, Nupur Nigam, Arati Sharma, Feng-Chun Yang, David F. Claxton, Yi Qiu, Peter D. Aplan, Mingjiang Xu, Suming Huang
Journal: Blood (2024)
Deciphering EZH2 Non-Canonical Activities in AML Resistance
Authors: Lia N'guyen, Emeline Boet, Camille Montersino, Claire Burny, Stéphane Audebert, Luc Camoin, Rémy Castellano, Sylvain Garciaz, Atsushi Iwama, Jean-Emmanuel Sarry, Estelle Duprez, Mathilde Poplineau
Journal: Blood (2024)
<i>A Novel in Vitro</i> Model of Pre-Leukemic Competition Reveals <i>“Super-Competitive”</i> TET2-Mutant Hematopoietic Stem Cell Clones
Authors: Lilia Cabrera-Cosme, Juan Rubio-Lara, Ellie Bennett, Joanna Milek, Maria Jassinskaja, Sandy MacDonald, Karen Hogg, Nicola K. Wilson, Berthold Gottgens, David Kent
Journal: Blood (2024)
Impacts of Monoallelic and Biallelic <i>DDX41</i> Mutations on Hematopoiesis and the Development of Myeloid Malignancies
Authors: Ayana Kon, Masahiro M Nakagawa, Azumi Tomita, Keisuke Kataoka, Nobuyuki Kakiuchi, Manabu Nakayama, Haruhiko Koseki, Hideki Makishima, Yasuhito Nannya, Seishi Ogawa
Journal: Blood (2024)
Mutation Analysis of the <i>ADAMTS13</i> Gene in Patients with Congenital Thrombotic Thrombocytopenic Purpura from the rADAMTS13 Phase 3 Study
Authors: Dorothée Diogo, Pinghai Zhang, Wolf-Achim Hassenpflug, Björn Mellgård, Parth Patwari, Wei Qu, Linda T. Wang
Journal: Blood (2024)
Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura - a Case Series with Long-Term Follow-up
Authors: Roman R. Schimmer, Jana Van Den Berg, Marissa Schraner, Alice Trinchero, Andreas Holbro, Johanna A. Kremer Hovinga, Jan-Dirk Studt
Journal: Blood (2024)
Caplacizumab in Immune-Mediated Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Literature Review and Meta-Analyses of Clinical Trials and Observational Studies
Authors: Paul Coppo, Marie Scully, Agathe Nevière, Pauline Le Nouveau, Prerna Patel, Alaeddine Sidhom, Srushhti Trivedi, Rachel Chu, Da Eun Ahn, Gabriela Marcheva, Divyesh Thakker, Gaye Siliman, Alix Arnaud
Journal: Blood (2024)
Genetic and Molecular Dynamics of <i>DDX41-</i>variants: Insights on the Variant Effect Prediction
Authors: Valeria Visconte, Carlos Bravo-Perez, Arda Durmaz, Zachary Brady, Luca Guarnera, Matteo D'Addona, Carmelo Gurnari, Chao-Yie Yang, Jaroslaw Maciejewski
Journal: Blood (2024)
Donor Trait Status Determines Haematological Outcomes Post-Haemopoietic Stem Cell Transplantation in Transfusion Dependent Thalassaemia Independent of HLA Matching and Chimerism Status
Authors: Kinza Khan, Farah O'Boyle, Kirstin Lund, Toni Petterson, Sandrine Bremathas, Kelly Hennessy, Adam Gassas, Leena Karnik, Josu de la Fuente
Journal: Blood (2024)
Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naïve Patients with Myelofibrosis
Authors: John O. Mascarenhas, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds, Alessandro M. Vannucchi, Francesca Palandri, Sung-Eun Lee, Vikas Gupta, Alessandro Lucchesi, Stephen Oh, Andrew T. Kuykendall, Andrea Patriarca, Alberto Alvarez-Larran, Ruben Mesa, Jean-Jacques Kiladjian, Moshe Talpaz, Morgan Harris, Sarah-Katharina Kays, Qing Li, Barbara Brown, Anna-Maria Jegg, Claire Harrison, Raajit Rampal
Journal: Blood (2024)
Small Activating RNA-Mediated Induction of <i>HBG</i> Via Liposome Delivery for <i>In Vivo</i> Treatment of Sickle Cell Disease and Beta-Thalassemia
Authors: Laura Sinigaglia, Marcella O'Reilly, Rhea Bhalla, Khoa Chung, Pardis Piri Dizaji, Victoria Begley, Rose Hodgson, Gabriela Lin, Konstantinos Vanezis, Julieta Tesone, Helen Paterson, Shreyasi Swamy, Henrik Hansen, Natalia Izotova, Bruno Doreste, Yulia Lomonosova, Luke Haslett, Robert Habib, Robert F Place, Jon Voutila, Vikash Reebye, Troels Koch, Brid M Ryan
Journal: Blood (2024)
Caplacizumab Resistance in Immune Thrombotic Thrombocytopenic Purpura (TTP) Mediated By VWF A1 Domain Missense Mutation
Authors: Mari Thomas, Imogen Buckle, Adela Constantinescu-Bercu, Rens De Groot, Arshia Latif, Sabina McCann, Marie Scully
Journal: Blood (2024)
Robust Immune Reconstitution in Fanconi Anemia Mice Post in Utero Hematopoietic Stem Cell Transplantation
Authors: Leah Swartzrock, Wenjing Pan, Mark R. Krampf, Hana Hoang, Morgane Denis, Taylor Cool, Katie Ho, Miranda Steele, Brittany Brown, Jian Han, Tippi C. MacKenzie, Agnieszka D. Czechowicz
Journal: Blood (2024)
A Novel Synthetic Short-Chain Polyphosphate (polyP) Complexed with Silica Nanoparticle (SNP) Improves Hemostatic Outcomes in Severe Swine and Rat Injury Models
Authors: Damien Kudela, Kyle Ploense, Genmin Lu, Charles Pollack, Andrea Ashford-Hicks, James H. Morrissey
Journal: Blood (2024)
Gene Therapy for Sickle Cell Disease Is Associated with a Decreased Transplant Length of Stay and Similar Rates of Short-Term Complications Compared to Allogeneic Matched Sibling Stem Cell Transplant: A Single Center Experience
Authors: Lev Gorfinkel, Erica B. Esrick, Alexander Lake, Miki Nishitani, Malika Kapadia, Amy Federico, Colleen Dansereau, David A. Williams, Leslie E. Lehmann
Journal: Blood (2024)
Refractory Cytopenia in Childhood Under Watch and Wait Strategy: Safe until Adulthood?
Authors: Beatrice Drexler, Stephan Schwarz-Furlan, Irith Baumann, Martina Rudelius, Peter Noellke, Dirk Lebrecht, Senthilkumar Ramamoorthy, Natalia Rotari, Axel Karow, Shinsuke Hirabayashi, Marcin Wlodarski, Fabian Beier, Yvonne Lisa Behrens, Gudrun Göhring, Reinhard Kalb, Brigitte Strahm, Miriam Erlacher, Charlotte Marie Niemeyer, Ayami Yoshimi
Journal: Blood (2024)
Beyond the Binary: Analysis of Sickle Cell Disease Crisis Hospitalizations in the Transgender Population in United States
Authors: Ahmad Basharat, Yuanli Lei, Jawad Noor, Atif N Khan, Ateeq Rehman, Maleeha Ajmal, Hania Latif Sami, Aqsa Mumtaz, Moazzam Shahzad
Journal: Blood (2024)
Inducible, Erythroid-Specific Knockout of Codanin-1 in Adult Mice Replicates Congenital Dyserythropoietic Anemia Type-Ia
Authors: Corbin R Azucenas, Aikaterini Voulgaridou, Maria Stewart, Athina Ntoumaziou, Yasmin Elgammal, Katie Seu, Theodosia A. Kalfa
Journal: Blood (2024)
Dietary Tryptophan Contributes to Indoleamine 2,3-Dioxygenase 1(IDO-1)-Mediated Cancer-Associated Venous Thrombogenicity in Mice
Authors: Asha Jose, Saran Lotfollahzadeh, Xiaosheng Yang, Tanvi Bathla, Adam Lazowski, Karlynn Dulberger, Jennifer La, Nathaniel Fillmore, Maria Del Carmen Piqueras, Norman Lee, Katya Ravid, Vipul Chitalia
Journal: Blood (2024)
Repolarisation of M2 Macrophages Via Cgas-Sting Activation Enhances Phagocytosis of Acute Myeloid Leukaemia
Authors: Matthew Markham, Rebecca S Maynard, George Bell, Katherine Hampton, Dominic James Fowler-Shorten, Alyssa Nicole Polski-Delve, Annalisa Altera, Rosie Taylor, Charlotte Hellmich, Kristian Bowles, Stuart A Rushworth
Journal: Blood (2024)
Combination with Palbociclib Overcomes Venetoclax Resistance Mechanisms and Outperforms Single Agent Efficacy in Acute Myeloid Leukemia
Authors: Melissa L Stewart, Jessica Gibbs, Daniel Bottomly, Andy Kaempf, Stephen E. Kurtz, Christopher A. Eide, Ariane Huang, Luca Sax, Nicola Long, Shannon K McWeeney, Bill H Chang, Jeffrey W. Tyner
Journal: Blood (2024)
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy
Authors: Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean-Jacques Kiladjian, Steffen Koschmeider, Harinder Gill, Kristen Pettit, David M Ross, Claire Harrison, Alejandro Berkovits, Ahmet Muzaffer Demir, Tsai-Yun Chen, Stefan Scheding, Claudia Barrera Carmona, Alessandro Vannuchi, Shiyu Zhang, Uzor C. Ogbu, Keita Kirito
Journal: Blood (2024)
External Validation of the French Score in Thrombotic Microangiopathies: Real-World Experience in a Large Retrospective Cohort of 1483 Patients
Authors: Alicia Cruz Gómez, María Martínez Rodríguez, Andrés Felipe Melo Arias, Clara Fernández Arias, Olatz Olabarri Etxebarria, Laura Sánchez Calvo, Maria José de la Osa Velacoracho, Kenneth Herrera Robles, Ana Tobalina García, Stefania Carvajal Altamiranda, Jorge Martínez Nieto, Ana Villegas, Alejandro Sánchez Saito, Miguel Gómez Álvarez, Sara Ferrer, Rafael López del Amo, Paloma Ropero Gradilla, Celina Benavente Cuesta, Fernando Ataulfo González Fernández, Gonzalo Del Campo Balguerías
Journal: Blood (2024)
TET1 Drives Myelodysplastic Syndromes and Represents a Promising Therapeutic Target
Authors: Chao Shen, Tingting Tang, Kitty Wang, Zunsong Hu, Yuan Che, Meiling Chen, Keren Zhou, Zhenhua Chen, Ying Qing, Wei Li, Dong Wu, Keith Leung, Lillian Sau, Zhaoxu Xu, Lucy Y. Ghoda, Guido Marcucci, Xiaolan Deng, Jianjun Chen
Journal: Blood (2024)
Phase 2 Trial of Siltuximab for the Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR-T Cell Therapy
Authors: Mayur S. Narkhede, Antonio Di Stasi, Lauren Kelly Shea, Susan Bal, Gayathri Ravi, Gaurav Goyal, Pamela Hardwick, Smith Giri, Donna Salzman, Ravi Bhatia, Luciano J. Costa, Amitkumar Mehta
Journal: Blood (2024)
Uncovering the HOXA9 Translational Regulatory Complex That Promotes AML Leukemic Stem Cells
Authors: Xueqin Xie, Florisela Herrejon Chavez, Ilyes Baali, Eren L. Chu, Chiara Evans, Xuejing Yang, Wei Wei, Hanzhi Luo, Sun Mi Park, Kathryn Chang, Aspen Pierson, Grace Han, Emily Batchelor, Quaid D. Morris, Ly Vu, Diu T.T. Nguyen, Michael G. Kharas
Journal: Blood (2024)
Olverembatinib (HQP1351) Overcomes Resistance/Intolerance to Asciminib and Ponatinib in Patients (pts) with Heavily Pretreated Chronic-Phase Chronic Myeloid Leukemia (CP-CML): A 1.5-Year Follow-up Update with Comprehensive Exposure-Response (E-R) Analyses
Authors: Elias Jabbour, Omer Jamy, Paul B. Koller, Vivian G. Oehler, Maria R. Baer, Elza Lomaia, Anthony M. Hunter, Olga Uspenskaya, Svetlana Samarina, Jorge E. Cortes, Sudipto Mukherjee, Dennis Dong Hwan Kim, Vera Zherebtsova, Vasily Shuvaev, Anna Turkina, Igor Davydkin, Huanshan Guo, Zi Chen, Hengbang Wang, Tommy Fu, Lixin Jiang, Zhihong Yang, Cunlin Wang, Dajun Yang, Yifan Zhai, Hagop Kantarjian
Journal: Blood (2024)
<i> <i>Ppara</i> </i> Deletion Promotes Monocytic Leukemia Granulocytic Differentiation
Authors: Moussa Diolombi, Anish V Sharda, Ming Chen, Leinal Sejour, Assaf Bester, Daphna Nachmani, John G. Clohessy, Pier Paolo Pandolfi, Lourdes M Mendez
Journal: Blood (2024)
IMA001 Is a Novel Therapeutic Molecule That Improves Hematological Parameters during Vaso-Occlusion in Sickle Cell Disease <i>In Vivo</i>
Authors: Marielle Margier, Giulia Scorrano, Cecile Cros, Julie Charmetant, Thiago Trovati Maciel, Ousmane Alfa Cisse, Wassim El Nemer, Matthias Canault
Journal: Blood (2024)
T Lymphopenia and Aged Immune System Characterize Immunodeficiency in Adult Patients with Telomere Biology Disorders
Authors: Luiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, Natthakan Thongon, Tania Rene Machado, Ivana Darden, Jennifer Lotter, Bhavisha A. Patel, Geraldine Aubert, Colin O. Wu, Simona Colla, Cynthia E. Dunbar, Fernanda Rodrigues, Emma M. Groarke
Journal: Blood (2024)
Myelodysplastic Syndrome Stem Cells Evaluated By Multiparameter Flow Cytometry Are Associated with Posttreatment Relapse: A Prospective Study
Authors: Wei-Bin Wu, Ya-Wen Luo, Siqi Li, Lanping Xu, Yu Wang, Xiaohui Zhang, Yuqian Sun, Feifei Tang, Xiaodong Mo, Kai-Yan Liu, Xiao-Su Zhao, Xiang-Yu Zhao, He-Bing Chen, Ying-Jun Chang, Xiaojun Huang
Journal: Blood (2024)
A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Authors: Sewon Lee, Yeung-Chul Mun, Hongtae Kim, Sung-Ho Park, Semin Lee, Seunghoon Kim, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Yoonsung Lee, Dong-Wook Kim
Journal: Blood (2024)
Cardiovascular Profile of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia: A 16-Year Observational Study
Authors: Hadil Zureigat, Ahmed N Mohamed, Muaz Alsabbagh Alchirazi, Parker Foster, Yasmine Elghoul, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Diego Ramonfaur, Brandon Francis, Sneha Govande, Emily C. Zabor, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Matt Kalaycio, Sudipto Mukherjee, Rohit Moudgil, Moaath K. Mustafa Ali
Journal: Blood (2024)
Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Ahmad Basharat, Matthew McGuirk, Peiman Hematti, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood (2024)
High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent Safety and Tolerability in CMML Patients in Combination with Azacitidine
Authors: Maha M Kamel, Nirmal Robinson, Monika Kutyna, Kelly Lim, Chloe Thompson-Peach, Steven W Lane, David T Yeung, Agnes S. M. Yong, David M Ross, Devendra Hiwase, Daniel Thomas
Journal: Blood (2024)
Efficacy and Safety of Mitoxantrone Hydrochloride Liposome in Combination with Thiotepa-Busulfan-Fludarabine As an Intensive Conditioning Regimen Preceding Salvage Allogeneic Stem Cell Transplantation in Relapsed or Refractory Acute Myeloid Leukemia
Authors: Xiaoning Wang, Juan Ren, Huachao Zhu, Yuqi Wang, Pengcheng He
Journal: Blood (2024)
A Phase II Study of Pembrolizumab+ BEAM before Autologous Stem Cell Transplant (ASCT) Followed By Pembrolizumab Maintenance in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma
Authors: Sanjal H. Desai, Qing Cao, Marie Hu, Joseph E. Maakaron, Veronika Bachanova
Journal: Blood (2024)
Vitamin D Deficiency Negatively Affects Responses in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
Authors: Vitida Chuengviroj, Piangrawee Niprapan, Teerachat Punnachet, Nonthakorn Hantrakun, Sasinee Hantrakool, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, Adisak Tantiworawit, Lalita Norasetthada, Pokpong Piriyakhuntorn
Journal: Blood (2024)